Rare diseases
Investigational molecules
Locations
Back to Hungary68 clinical trials in Veszprem, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
HungaryEvaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
HungaryStudy on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
HungaryStudy on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)
HungaryStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis Who Have Not Responded Well to Previous Biologic Treatments
HungaryA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
HungaryStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
HungaryStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
HungaryStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
HungaryHungaryA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
HungaryStudy of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for moderate to severe plaque psoriasis, including investigations of innovative therapies like JNJ-77242113 and ESK-001.
Multiple trials focusing on efficacy assessment and treatment response durability.
Extensive research into psoriatic arthritis treatments, including trials with zasocitinib, sonelokimab, and deucravacitinib for both biologic-naïve and experienced patients.
Focus on reducing symptoms and improving quality of life for patients.
Innovative research targeting systemic lupus erythematosus and other inflammatory conditions, with studies on medications like GLPG3667 and upadacitinib.
Comprehensive evaluation of disease activity and treatment responses.
Studies examining treatments for knee osteoarthritis, including comparative analysis of different chondroitin sulfate formulations and novel compounds.
Focus on both symptom management and functional outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
